Abstract
A series of new pyrazolic heterocyclic compounds were prepared in good and excellent yields and characterized by proton and carbon nuclear magnetic resonance, infrared, and mass spectroscopy studies. These products were screened in vitro against three bacterial pathogens, namely Bacillus subtilis, Micrococcus luteus, and Escherichia coli and antifungal potential, against Fusarium oxysporum f.sp.albedinis. A considerable and excellent activity was recorded with respect to the two studied microorganisms. A good correlation was obtained between the experimental results and the theoretical predictions of bioavailability using Petra/Osiris/Molinspiration suite (Petra/Osiris/Molinspiration containing Lipinski’s rule-of-five). The quantitative structure activity relationship approach has been analyzed to support the Petra/Osiris/Molinspiration results and composite indexes of some quantum chemical parameters were constructed in order to characterize the inhibition performance of the tested molecules.
Similar content being viewed by others
References
Abrigach F, Khoutoul M, Benchat N, Radi S, Draoui N, Feron O, Riant O, Touzani R (2014) Library of synthetic compounds based on pyrazole unit: design and screening against breast and colorectal cancer. Lett Drug Des Discov 11:1010–1016
Al Houari G, Kerbal A, Bennani B, Baba MF, Daoudi M, Ben Hadda T (2008) Drug design of new antitubercular agents: 1,3-dipolar cycloaddition reaction of arylnitriloxides and 3-para-methoxybenzylidene-isochroman-4-ones. Arkivoc 12:42–50
Bailey DM, Hansen PE, Hlavac AG, Baizman ER, Pearl J, Defelice AF, Feigenson ME (1985) 3,4-Diphenyl-1H-pyrazole-1-propanamine antidepressants. J Med Chem 28:256–260
Bayrak H, Demirbas A, Karaoglu SA, Demirbas N (2009) Synthesis of some new 1,2,4-triazoles, their Mannich and Schiff bases and evaluation of their antimicrobial activities. Eur J Med Chem 44:1057–1066
Ben Hadda T, Fathi J, Chafchaouni I, Masand V, Charrouf Z, Chohan ZH, Jawarkar R, Fergoug T, Warad I (2013) Computational POM and 3D-QSAR evaluation of experimental in vitro HIV-1-Integrase inhibition of amide-containing diketoacids. Med Chem Res 22:1456–1464
Bouabdallah I, M’barek LA, Zyad A, Ramadan A, Zidane I, Melhaoui A (2006) Anticancer effect of three pyrazole derivatives. Nat Prod Res 20:1024–1030
Boussalah N, Touzani R, Bouabdallah I, El Kadiri S, Ghalem S (2009) Synthesis, structure and catalytic properties of tripodal amino-acid derivatized pyrazole-based ligands. J Mol Catal A Chem 306:113–117
Boussalah N, Touzani R, Souna F, Himri I, Bouakka M, Hakkou A, Ghalem S, El Kadiri S (2013) Antifungal activities of amino acid ester functionalpyrazolyl compounds against Fusarium oxysporum f.sp.albedinis and Saccharomyces cerevisiae yeast. J Saudi Chem Soc 17:17–21
Chu CK, Cutler J (1986) Chemistry and antiviral activities of acyclonucleosides. J Heterocycl Chem 23:289–319
Dewar MJS, Zoebisch EG, Healy EF, Stewart JJP (1985) Development and use of quantum mechanical molecular models. AM1: a new general purpose quantum mechanical molecular model. J Am Chem Soc 107:3902–3909
Douglas SJ, Jie JL (2007) The Art of drug synthesis. Wiley, Hoboken, NJ
Dvoretzky R, Holmes G (1950) Formaldehyde condensation in the pyrazole series. J Org Chem 15:1285–1288
El Kodadi M, Malek F, Ramdani A (2004) 1-(4-{[(3,5-dimethyl-1H-pyrazol-1-yl)methyl] amino} phenyl) ethanone. Molbank 1:M369
El-youbi M, Benabbes R, Lahmass I, Abrigach F, Khoutoul M, Benchat N, Bouakka M, Touzani R, Saalaoui E (2015) Antibacterial and antifungal activities of new pyrazolic compounds. Moroccan J Biol 12:9–13
Ertl P, Rohde B, Selzer P (2003) Fast calculation of molecular Polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714–3717
Fang B, Cheng HZ, Xian CR (2010) Synthesis and biological activities of novel amine-derived bis-azoles as potential antibacterial and antifungal agents. Eur J Med Chem 45:4388–4398
Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Keith T, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken B, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski KG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas O, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ (2010) Gaussian 09, Revision D.01. Gaussian, Inc., Wallingford CT
Goodarzi M, Freitas MP, Ghasemi N (2010) QSAR studies of bioactivities of 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 receptor ligands using physicochemical descriptors and MLR and ANN-modeling. Eur J Med Chem 45:3911–3915
Haufel J, Breitmaier E (1974) Synthesis of pyrazolo heteroaromatic compounds by means of 5-amino-3-methyl-l-phenylpyrazole-4-carbaldehyde. Angew Chem 13:604–604
Janus SL, Magdif AZ, Erik PB, Claus N (1999) Synthesis of triazenopyrazole derivatives as potential inhibitors of HIV-1. Monatsh Chem 130:1167–1174
Khoutoul M, Abrigach F, Zarrouk A, Benchat N, Lamsayah M, Touzani R (2015) New nitrogen donor pyrazolic ligands for an excellent liquid–liquid extraction of Fe2+ metal ion in aqueous solution with theoretical study. Res Chem Intermed 41:3319–3334
Luilo GB, Cabaniss SE (2010) Quantitative structure−property relationship for predicting chlorine demand by organic molecules. Environ Sci Technol 44:2503–2508
Manfredini S, Baraldi PG, Bazzanini R, Durini E, Vertuani S, Pani A, Marceddu T, Demontis F, Vargiu L, La Colla P (2000) Pyrazole related nucleosides 5. Synthesis and biological activity of 2′-deoxy-2′,3′-dideoxy- and acyclo-analogues of 4-iodo-1-beta-d-ribofuranosyl-3-carboxymethyl pyrazole. Nucleosides Nucleotides Nucleic Acids 19:705–722
Michon V, DuPenhoat CH, Tombret F, Gillardin JM, Lepagez F, Berthon L (1995) Preparation, structural analysis and anticonvulsant activity of 3- and 5-aminopyrazole N-benzoyl derivatives. Eur J Med Chem 30:147–155
Nilesh JT, Manish PP (2011) Synthesis, characterization, and antimicrobial evaluation of carbostyril derivatives of 1H-pyrazole. Saudi Pharm J 19:75–83
Olajuyigbe OO, Oyedeji O, Adedayo O (2014) Evaluation of the vitro interaction of amoxicillin and cotrimoxazole antibiotics against resistant bacterial strains. J Appl Pharm Sci 4:94–100
Papa E, Kovarich S, Gramatica P (2010) QSAR modeling and prediction of the endocrine-disrupting potencies of brominated flame retardants. Chem Res Toxicol 23:946–954
Park HJ, Lee K, Park S, Ahn B, Lee JC, Cho HY, Lee KI (2005) Identification of antitumor activity of pyrazole oxime ethers. Bioorg Med Chem Lett 15:3307–3312
Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6:29–40
Pimerova EV, Voronina EV (2001) Antimicrobial activity of pyrazoles and pyridazines obtained by interaction of 4-aryl-3-arylhydrazono-2,4-dioxobutanoic acids and their esters with hydrazines. Pharm Chem J 35:602–604
Pourbasheer E, Riahi S, Ganjali MR, Norouzi P (2010) Quantitative structure–activity relationship (QSAR) study of interleukin-1 receptor associated kinase 4 (IRAK-4) inhibitor activities by the genetic algorithm and multiple linear regression (GA-MLR) method. J Enzyme Inhib Med Chem 25:844–853
Solomon C, Breckon T (2011) Fundamentals of digital image processing: A practical approach with examples in Matlab. John Wiley & Sons, Ltd., Publication.
Tetko IV, Gasteiger J, Todeschini R, Mauri A, Livingstone D, Ertl P, Palyulin VA, Radchenko EV, Zefirov NS, Makarenko AS, Tanchuk VY, Prokopenko VV (2005) Virtual computational chemistry laboratory - design and description. J Comput Aid Mol Des 19:453–463
Tewari AK, Mishra A (2001) Synthesis and anti-inflammatory activities of N4,N5-disubstituted-3-methyl-1H-pyrazolo[3,4-c]pyridazines. Bioorg Med Chem 9:715–718
Wallace D (2009) Rapid culture methods for the microbiological examination of foods. Food Sci Technol 23:44–45
Wiley RH, Wiley P (1964) Chemistry of heterocyclic compounds: pyrazolones, pyrazolidones, and derivatives. Wiley, New York, Vol 20
Wustrow DJ, Capiris T, Rubin R, Knobelsdorf JA, Akunne H, Davis MD, MacKenzie R, Pugsley TA, Zoski KT, Heffner TG, Wise LD (1998) Pyrazolo[1,5a]pyrimidine CRF-1 receptor antagonists. Bioorg Med Chem Lett 8:2067–2070
Yildirim I, Ozdemir N, Akçamur Y, Dinçer M, Andaç O (2005) 4-Benzoyl-1,5-diphenyl-1H-pyrazole-3-carboxylic acid methanol solvate. Acta Cryst E61:256–258
Acknowledgements
The authors want to thank professor Olivier Riant from UNIVERSITE CATHOLIQUE DE LOUVAIN, Institut de la Matière Condensée et des Nanosciences (IMCN), Pôle Molécules, Solides et Réactivité (MOST), the CUD of Belgium and the CNRST of Morocco for its generous support.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors confirm that this article content has no conflict of interest.
Rights and permissions
About this article
Cite this article
Abrigach, F., Karzazi, Y., Benabbes, R. et al. Synthesis, biological screening, POM, and 3D-QSAR analyses of some novel pyrazolic compounds. Med Chem Res 26, 1784–1795 (2017). https://doi.org/10.1007/s00044-017-1888-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-017-1888-8